A Global Pathogen Detection System

Investigating the social, ethical, and institutional dimensions of genomics, data, and AI in global pathogen surveillance

Apply Now

Project Summary 

This DPhil project aims to investigate the social, ethical, and institutional dimensions of emerging technologies central to the Pathogen Program's mission to transform infectious disease diagnosis and response. The Pathogen Program is building a global pathogen monitoring ecosystem using frontier approaches such as metagenomics, federated data infrastructures, and AI. Alongside striving for scientific excellence, the program is committed to proactively incorporating the ethical, legal, and social implications (ELSI) of these technologies to ensure their responsible, equitable, and effective deployment. 

This project aims to embed a rigorous socio-technical research project within the Pathogen Program’s activities, exploring how new challenges can be anticipated and governed through academically grounded methods and real-world insight. It is anticipated that the candidate will apply mixed methods, such as ethnography, co-design, policy analysis or technical audits, to examine how tools and platforms are developed, implemented, and sustained across diverse health systems. 

The project is intentionally broad, with the expectation that the DPhil candidate will explore up to three focus areas based on their background, areas of interest and most urgent need of the program. Illustrative research questions include: 

  • How can diagnostic devices be co-designed to build trust, equity, and usability in diverse care settings? 
  • What frameworks enable clinical diagnostics to function as both patient tools and public health sensors? 
  • How can federated data platforms balance data sovereignty, public health goals, and equitable participation? 
  • What governance mechanisms support responsible cross-border data sharing? 
  • How can bias detection, transparency, and explainability be built into AI outbreak detection systems? 
  • What makes digital tools adaptable and trustworthy across different health system contexts? 
  • How can global surveillance efforts be sustainably coordinated and governed as a public good? 

Potential Supervisors 

  • Professor Gil McVean (Principal Scientist, Pathogen Program, EIT & Professor of Statistical Genetics, Department of Statistics and the Nuffield Department of Medicine, University of Oxford)  
  • Dr Maxine Mackintosh (Pathogen Program & Associate Researcher, University of Oxford)  
  • Ethox representative to be confirmed  

Skills Recommended 

  • Qualitative research methods: ethnography, narrative interviews, participatory design 
  • Foundational understanding of science and technology studies (STS), bioethics, and health systems 
  • Technical literacy in genomics workflows, diagnostic devices, and machine learning pipelines 
  • Mixed-methods competencies: network analysis, comparative policy review, regulatory mapping 
  • Stakeholder facilitation and engagement across clinical, technical, and community domains 

Skills to be Developed 

  • Algorithmic audit methods and fairness assessment frameworks 
  • Advanced co-design and translational research facilitation with interdisciplinary teams 
  • Comparative legal and policy analysis of data governance and global health law 
  • Governance toolkit development and evaluation metrics for real-world implementation 
  • Strategic communication of socio-technical risks to non-specialist and policy audiences 

University DPhil Courses

A range of possible DPhil courses may include: ‍

Relevant Background Reading 

  • Panteli, D., et al. (2025). Artificial intelligence in public health: Promises, challenges, and an agenda for policy makers and public health institutions. The Lancet Public Health, 10(5), e428–e432. 
  • Black, A., MacCannell, D. R., Sibley, T. R., et al. (2020). Ten recommendations for supporting open pathogen genomic analysis in public health. Nature Medicine, 26, 832–841. 
  • Moodley, K., et al. (2022). Ethics and governance challenges related to genomic data sharing in southern Africa: The case of SARS-CoV-2. The Lancet Global Health, 10(12), e1855–e1859. 
  • Shaw, J., & Sekalala, S. (2023). Health data justice: Building new norms for health data governance. npj Digital Medicine, 6, 30.  
  • Zhai, Y., Hong, G., Jiang, M., & Wei, Q. (2022). Access and benefit-sharing of pathogenic microorganisms such as SARS-CoV-2. Biosafety and Health, 4(6), 414–420. 
  • Schwalbe, N., et al. (2020). Artificial intelligence and the future of global health. The Lancet, 395(10236), 1579–1586. 
  • Greenbaum, D., Gurwitz, D., & Joly, Y. (2022). Editorial: COVID-19 pandemics: Ethical, legal and social issues. Frontiers in Genetics, 13, Article 1021865. 

‍

Supervisors

We are bringing together experts from across the globe, with a shared drive to create lasting impact.

Director of the Oxford Vaccine Group, Ashall Professor of Infection & Immunity

Professor Sir Andrew Pollard

Correlates of Immunity

Director of the Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford.

Principal Scientist, Pathogen Program & Member of the Board of Directors

Professor Gil McVean

Principal Scientist, Pathogen Program & Member of the Board of Directors. Professor of Statistical Genetics at the Department of Statistics and the Nuffield Department of Medicine, University of Oxford.

Principal Scientist, Plant Biology Institute & Member of the Board of Directors

Professor Steve Kelly

Principal Scientist Plant Biology Institute & Member of the Board of Directors at EIT. Professor of Plant Sciences and Senior Research Fellow of the Queens College, University of Oxford.

Executive Director & Principal Scientist

Dr Danilo Jimenez Rezende

AI & Robotics Institute

Executive Director & Principal Scientist for AI & Robotics at EIT. Former Director at Google DeepMind.

Executive Director & Executive Vice President

Dr Matej Macak

AI & Robotics Institute

Executive VP, AI & Robotics at EIT. Chief Technologist at Every Cure.

Principal Scientist, Economics

Professor Andrew Scott CBE

Economics

Principal Scientist of Economics, Economics Professor at University of Oxford. Research covers economics and longevity in aging societies.

Executive Director & Principal Scientist, Materials & Devices for Life Sciences

Professor Hagan Bayley

Materials & Devices for Life Sciences

Professor of Chemical Biology at the University of Oxford. Founder of Oxford Nanopore Technologies. Fellow of the Royal Society.

Founding Director, Generative Biology Institute

Professor Jason Chin

Generative Biology Institute

Founding Director, of the Generative Biology Institute (GBI) and Professor of Chemistry and Chemical Biology at the University of Oxford.

Research Scientist

Dr Ben Chamberlain

AI & Robotics Institute

Research Scientist in the AI & Robotics Institute at EIT. Previously held leadership roles at biotechs Isomorphic Labs and Charm Therapeutics.

Senior Director Device Science

Dr James Clarke

Senior Director of Product Science in the Pathogen Project at EIT.

Principal Investigator

Dr Jérôme Zürcher

Generative Biology Institute

Principal Investigator within GBI at EIT. Former junior research fellow at Trinity College, Cambridge and visiting researcher at the Innovative Genomics Institute at UC Berkeley.

Group Leader

Dr Linna Zhou

Materials & Devices for Life Sciences
Program Co-Lead

Professor Daniela Ferreira

Correlates of Immunity

Professor of Mucosal Immunology and Vaccinology at the Oxford Vaccine Group, Paediatrics Department, University of Oxford.

Senior Director, Science Applications

Professor Justin O'Grady

Pathogen Program

Senior Director of Science Applications in the Pathogen Program at EIT. Honorary Professor at the University of East Anglia.

Senior Group Leader

Professor Yujia Qing

Materials & Devices for Life Sciences

A Senior Group Leader in the Materials & Devices for the Life Sciences program at EIT. An Associate Professor in the Department of Chemistry, University of Oxford

Staff Scientist, AMR and Applied Metagenomics

Dr Vicky Enne

Pathogen Program
Senior Group Leader, Cell Based Production

Professor Lee Sweetlove

Plant Biology Institute